AtriCure Inc.

41.77-1.31-3.04%Vol 307.75K1Y Perf -40.75%
May 18th, 2022 16:00 DELAYED
BID37.47 ASK43.07
Open42.08 Previous Close43.08
Pre-Market- After-Market41.77
 - -  - -%
Target Price
82.83 
Analyst Rating
Strong Buy 1.50
Potential %
98.30 
Finscreener Ranking
★★★★     54.28
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★+     58.14
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     70.03
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
6.19 
Earnings Rating
Sell
Market Cap1.93B 
Earnings Date
3rd May 2022
Alpha0.01 Standard Deviation0.12
Beta1.19 

Today's Price Range

41.3342.75

52W Range

38.6489.18

5 Year PE Ratio Range

-45.30-24.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
8.82%
1 Month
-22.93%
3 Months
-30.21%
6 Months
-43.88%
1 Year
-40.75%
3 Years
46.43%
5 Years
103.40%
10 Years
441.21%

TickerPriceChg.Chg.%
ATRC41.77-1.3100-3.04
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
3.20
4.20
0.14
0.16
12.00
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
74.90
19.60
23.50
-16.60
17.93
RevenueValueIndustryS&P 500US Markets
289.63M
6.26
8.11
9.99
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.33-0.330.00
Q04 2021-0.26-0.30-15.38
Q03 2021-0.28-0.2317.86
Q02 2021-0.30-0.300.00
Q01 2021-0.38-0.3215.79
Q04 2020-0.26-0.1830.77
Q03 2020-0.33-0.1166.67
Q02 2020-0.59-0.3835.59
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.28-12.00Negative
9/2022 QR-0.26-18.18Negative
12/2022 FY-1.09-17.20Negative
12/2023 FY-0.91-24.66Negative
Next Report Date-
Estimated EPS Next Report-0.33
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume307.75K
Shares Outstanding46.29K
Shares Float45.22M
Trades Count7.46K
Dollar Volume12.92M
Avg. Volume310.23K
Avg. Weekly Volume350.16K
Avg. Monthly Volume326.26K
Avg. Quarterly Volume254.29K

AtriCure Inc. (NASDAQ: ATRC) stock closed at 43.08 per share at the end of the most recent trading day (a 3.96% change compared to the prior day closing price) with a volume of 312.85K shares and market capitalization of 1.93B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 730 people. AtriCure Inc. CEO is Michael H. Carrel.

The one-year performance of AtriCure Inc. stock is -40.75%, while year-to-date (YTD) performance is -38.04%. ATRC stock has a five-year performance of 103.4%. Its 52-week range is between 38.64 and 89.18, which gives ATRC stock a 52-week price range ratio of 6.19%

AtriCure Inc. currently has a PE ratio of 38.30, a price-to-book (PB) ratio of 4.29, a price-to-sale (PS) ratio of 6.62, a price to cashflow ratio of 255.30, a PEG ratio of 2.32, a ROA of 8.08%, a ROC of 11.21% and a ROE of 12.16%. The company’s profit margin is 17.93%, its EBITDA margin is 23.50%, and its revenue ttm is $289.63 Million , which makes it $6.26 revenue per share.

Of the last four earnings reports from AtriCure Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.33 for the next earnings report. AtriCure Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for AtriCure Inc. is Strong Buy (1.5), with a target price of $82.83, which is +98.30% compared to the current price. The earnings rating for AtriCure Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AtriCure Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

AtriCure Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.31, ATR14 : 3.31, CCI20 : -78.10, Chaikin Money Flow : -0.27, MACD : -5.05, Money Flow Index : 38.90, ROC : -17.04, RSI : 33.58, STOCH (14,3) : 21.99, STOCH RSI : 1.00, UO : 35.71, Williams %R : -78.01), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AtriCure Inc. in the last 12-months were: Angela L. Wirick (Sold 8 543 shares of value $697 707 ), Douglas J. Seith (Sold 28 509 shares of value $2 190 660 ), Justin J. Noznesky (Option Excercise at a value of $549 000), Justin J. Noznesky (Sold 50 238 shares of value $3 866 160 ), Karl S. Dahlquist (Sold 336 shares of value $26 722 ), Mark A. Collar (Option Excercise at a value of $84 000), Mark A. Collar (Sold 7 000 shares of value $562 470 ), Regina Groves (Sold 7 364 shares of value $538 613 ), Robert S. White (Option Excercise at a value of $127 200), Salvatore Privitera (Sold 18 808 shares of value $1 568 680 ), Tonya Austin (Sold 24 253 shares of value $1 644 450 ), Vinayak Doraiswamy (Sold 7 672 shares of value $637 697 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (66.67 %)
5 (71.43 %)
4 (66.67 %)
Moderate Buy
1 (16.67 %)
1 (14.29 %)
1 (16.67 %)
Hold
1 (16.67 %)
1 (14.29 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.43
Strong Buy
1.50

AtriCure Inc.

AtriCure Inc an atrial fibrillation solutions company that provides products, professional education, and support for clinical science to reduce the economic and social burden of atrial fibrillation. Its products line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offer a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

CEO: Michael H. Carrel

Telephone: +1 513 755-4100

Address: 7555 Innovation Way, Mason 45040, OH, US

Number of employees: 730

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

77%23%

Bearish Bullish

69%31%

Bearish Bullish

69%31%

TipRanks News for ATRC

Wed, 16 Feb 2022 11:45 GMT Atricure (ATRC) Gets a Buy Rating from Needham

- TipRanks. All rights reserved.

Mon, 10 Jan 2022 13:15 GMT Atricure (ATRC) Receives a Buy from Needham

- TipRanks. All rights reserved.

News

Stocktwits